Alprazolam / Propranolol Tablet 0.25mg + 20mg Suppliers & Bulk Manufacturers

Available Forms: Tablets

Available Strengths: 0.25mg + 20mg

Reference Brands: -

Category: Antipsychotropic Drugs

Alprazolam + propranolol tablets (0.25 mg + 20 mg) combine a benzodiazepine with a beta-blocker for anxiety with physical symptoms such as palpitations and tremor. The combination is marketed in India, not in the US or EU. It is a controlled medicine in most countries, so we check the buyer's import permits before quoting.

Product Description:

A 6-week double-blind, controlled clinical study was conducted to evaluate the efficacy of propranolol hydrochloride and alprazolam in patients diagnosed with agoraphobia with panic disorder or panic disorder with or without limited phobic avoidance. The study included 29 patients, where 14 patients received alprazolam at a mean daily dose of 5.0 ± 2.3 mg, while 15 patients were treated with propranolol at a mean daily dose of 182.0 ± 60.5 mg.

The findings demonstrated that both alprazolam and propranolol were effective in suppressing panic attacks and reducing avoidance behavior associated with these conditions. Alprazolam, a benzodiazepine, showed a more rapid onset of its panicolytic effect, providing quicker symptomatic relief. Propranolol, a non-selective beta-blocker, also contributed to the management of physical symptoms related to anxiety and panic, such as palpitations and tremors.

Although alprazolam demonstrated faster action, propranolol showed promising results and may serve as a useful therapeutic option, particularly in patients where control of somatic symptoms is required. The study suggests that propranolol warrants further clinical evaluation to better define its role in the treatment of panic-related disorders.

Controlled medicine — licensed supply only

This product is controlled in many countries under narcotic, psychotropic, precursor or other drug laws, which vary by country. We supply only licensed buyers holding any import certificate, permit or authorisation their national authority requires, and the Indian manufacturer or exporter must hold the required licences. In India, each export of a narcotic drug or psychotropic substance needs an export authorisation, and export of ephedrine, pseudoephedrine or their preparations a No Objection Certificate, from the Narcotics Commissioner (Central Bureau of Narcotics). We verify permits before quoting.